03/28/2022 | Aleksandra Jones
Sitting Down With… Andrii Ruban, President of the Ukrainian Vitreoretinal Society, based in Kyiv, Ukraine
03/22/2022 | Aleksandra Jones
Uliana Tomkiv, a medical retina specialist from Lviv, Ukraine, describes how the recent Russian invasion has affected ophthalmologists
03/11/2022 | Geoffrey Potjewyd
For the first time, the development of the eye is tracked in real time at a cellular level
03/10/2022 | Geoffrey Potjewyd
Can we repair the visual and cognitive damage caused by long COVID?
03/08/2022 | Oscelle Boye
Researchers probe the origin of spaceflight-associated neuro-ocular syndrome
03/07/2022 | Geoffrey Potjewyd
How do you convince your droid to switch to an artificial retina?
02/28/2022 | Geoffrey Potjewyd
Kapil Bharti of NEI explains the importance of rare disease research and his progress for Rare Disease Day 2022
02/15/2022 | Geoffrey Potjewyd
Meet the latest potential addition to the retinal cell family: the Campana cell!
02/09/2022 | Aleksandra Jones
Can the gap between retina age and real age be used as an evaluation of patients’ risk of death?
02/07/2022 | Sponsored by PolyPhotonix
PolyPhotonix names Prevail Partners as its lead US investor whose affiliate will lead Noctura 400 FDA clinical trials
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: